Cardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles
Herausgeber: Cassee, Flemming R; Newby, David E; Mills, Nicholas L
Cardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles
Herausgeber: Cassee, Flemming R; Newby, David E; Mills, Nicholas L
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions.
Andere Kunden interessierten sich auch für
- Giorgio MinottiCardiotoxicity of Non-Cardiovascular Drugs166,99 €
- Fundamental Neuropathology for Pathologists and Toxicologists189,99 €
- Q Alan XuAnalytical Methods for Therapeutic Drug Monitoring and Toxicology208,99 €
- Developmental Neurotoxicology Research206,99 €
- Raimo PohjanvirtaThe Ah Receptor in Biology and Toxicology194,99 €
- Quantitative Modeling in Toxicology182,99 €
- Anticholinesterase Pesticides206,99 €
-
-
-
This book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions.
Produktdetails
- Produktdetails
- Verlag: John Wiley & Sons / Wiley
- Seitenzahl: 604
- Erscheinungstermin: 1. März 2011
- Englisch
- Abmessung: 246mm x 164mm x 37mm
- Gewicht: 1045g
- ISBN-13: 9780470433539
- ISBN-10: 0470433531
- Artikelnr.: 30977089
- Verlag: John Wiley & Sons / Wiley
- Seitenzahl: 604
- Erscheinungstermin: 1. März 2011
- Englisch
- Abmessung: 246mm x 164mm x 37mm
- Gewicht: 1045g
- ISBN-13: 9780470433539
- ISBN-10: 0470433531
- Artikelnr.: 30977089
Flemming R. Cassee is head of the Department of Inhalation Toxicology, deputy head of the Center for Environmental Health, and leader of the program on air pollution and health at the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Nicholas L. Mills is a British Heart Foundation Clinical Fellow at the University of Edinburgh and Specialist Registrar in Cardiology at the Royal Infirmary of Edinburgh. David E. Newby is the British Heart Foundation John Wheatley Chair of Cardiology at the University of Edinburgh. He is a Consultant Interventional Cardiologist at the Royal Infirmary of Edinburgh, Director of the Wellcome Trust Clinical Research Facility, Director of the Clinical Research Imaging Centre, and Director of Research and Development for NHS Lothian.
FOREWORD. PREFACE. THE EDITORS. CONTRIBUTORS. PART I. ISSUE FRAMING.
CHAPTER 1 OVERVIEW (Flemming R. Cassee and Morton Lippmann). CHAPTER 2
ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION
(Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth). CHAPTER 3 CHRONIC
EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan,
Joel Kaufman, and Gerard Hoek). PART II. EXPOSURE. CHAPTER 4 PARTICLE
CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach). CHAPTER 5
EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef
Cyrys, H.-Erich Wichmann, and Jeroen de Hartog). CHAPTER 6 FROM EXPOSURE TO
DOSE (Werner Hofmann and Bahman Asgharian). CHAPTER 7 TRANSLOCATION OF
INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid,
Manuela Semmler-Behnke, and Günter Oberdörster). CHAPTER 8 ROLE OF CHEMICAL
COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew
J. Ghio and Yuh-Chin T. Huang). PART III. METHODOLOGY. CHAPTER 9 IN VITRO
STUDIES (Per E. Schwarze and Gerrit M. Alink). CHAPTER 10 EXPERIMENTAL
STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L.
Costa). CHAPTER 11 HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W.
Frampton, and Anders Blomberg). CHAPTER 12 PANEL STUDIES (Joel Schwartz).
PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. A.
ATHEROGENESIS. CHAPTER 13 PARTICULATES AND OXIDATIVE STRESS (Steffen Loft,
Roel P.F. Schins, and Peter Møller). CHAPTER 14 ROLE OF INFLAMMATION IN THE
ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David
Newby). CHAPTER 15 INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR
POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS
(Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler). CHAPTER
16 INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara
Hoffmann and Nino Künzli). CHAPTER 17 EFFECTS OF NANOPARTICLES ON THE
PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl,
and Dennis W. Wilson). CHAPTER 18 PARTICULATE MATTER, HYPERTENSION, AND THE
METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan). CHAPTER 19
PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R.
Miller). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. B.
VASCULAR DYSFUNCTION. PART IV. PARTICLES AND CARDIOVASCULAR DISEASE:
MECHANISMS. C. THROMBOSIS. CHAPTER 20 PARTICLES, COAGULATION, AND
THROMBOSIS (Evren Kilinç, Goran Rude~, Henri M.H. Spronk, Abderrahim
Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts). CHAPTER
21 PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and
Xiaohua Xu). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. D.
ARRHYTHMIA. CHAPTER 22 PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna
Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz). CHAPTER 23 AIR
POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend). PART
V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY. CHAPTER 24 RISK ASSESSMENT
(Robert L. Maynard and Jon G. Ayres). CHAPTER 25 ENVIRONMENTAL REGULATION
OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and
Sophie Punte). CHAPTER 26 FROM AMBIENT ULTRAFINE PARTICLES TO
NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).
INDEX.
CHAPTER 1 OVERVIEW (Flemming R. Cassee and Morton Lippmann). CHAPTER 2
ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION
(Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth). CHAPTER 3 CHRONIC
EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan,
Joel Kaufman, and Gerard Hoek). PART II. EXPOSURE. CHAPTER 4 PARTICLE
CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach). CHAPTER 5
EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef
Cyrys, H.-Erich Wichmann, and Jeroen de Hartog). CHAPTER 6 FROM EXPOSURE TO
DOSE (Werner Hofmann and Bahman Asgharian). CHAPTER 7 TRANSLOCATION OF
INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid,
Manuela Semmler-Behnke, and Günter Oberdörster). CHAPTER 8 ROLE OF CHEMICAL
COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew
J. Ghio and Yuh-Chin T. Huang). PART III. METHODOLOGY. CHAPTER 9 IN VITRO
STUDIES (Per E. Schwarze and Gerrit M. Alink). CHAPTER 10 EXPERIMENTAL
STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L.
Costa). CHAPTER 11 HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W.
Frampton, and Anders Blomberg). CHAPTER 12 PANEL STUDIES (Joel Schwartz).
PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. A.
ATHEROGENESIS. CHAPTER 13 PARTICULATES AND OXIDATIVE STRESS (Steffen Loft,
Roel P.F. Schins, and Peter Møller). CHAPTER 14 ROLE OF INFLAMMATION IN THE
ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David
Newby). CHAPTER 15 INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR
POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS
(Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler). CHAPTER
16 INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara
Hoffmann and Nino Künzli). CHAPTER 17 EFFECTS OF NANOPARTICLES ON THE
PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl,
and Dennis W. Wilson). CHAPTER 18 PARTICULATE MATTER, HYPERTENSION, AND THE
METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan). CHAPTER 19
PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R.
Miller). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. B.
VASCULAR DYSFUNCTION. PART IV. PARTICLES AND CARDIOVASCULAR DISEASE:
MECHANISMS. C. THROMBOSIS. CHAPTER 20 PARTICLES, COAGULATION, AND
THROMBOSIS (Evren Kilinç, Goran Rude~, Henri M.H. Spronk, Abderrahim
Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts). CHAPTER
21 PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and
Xiaohua Xu). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. D.
ARRHYTHMIA. CHAPTER 22 PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna
Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz). CHAPTER 23 AIR
POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend). PART
V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY. CHAPTER 24 RISK ASSESSMENT
(Robert L. Maynard and Jon G. Ayres). CHAPTER 25 ENVIRONMENTAL REGULATION
OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and
Sophie Punte). CHAPTER 26 FROM AMBIENT ULTRAFINE PARTICLES TO
NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).
INDEX.
FOREWORD. PREFACE. THE EDITORS. CONTRIBUTORS. PART I. ISSUE FRAMING.
CHAPTER 1 OVERVIEW (Flemming R. Cassee and Morton Lippmann). CHAPTER 2
ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION
(Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth). CHAPTER 3 CHRONIC
EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan,
Joel Kaufman, and Gerard Hoek). PART II. EXPOSURE. CHAPTER 4 PARTICLE
CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach). CHAPTER 5
EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef
Cyrys, H.-Erich Wichmann, and Jeroen de Hartog). CHAPTER 6 FROM EXPOSURE TO
DOSE (Werner Hofmann and Bahman Asgharian). CHAPTER 7 TRANSLOCATION OF
INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid,
Manuela Semmler-Behnke, and Günter Oberdörster). CHAPTER 8 ROLE OF CHEMICAL
COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew
J. Ghio and Yuh-Chin T. Huang). PART III. METHODOLOGY. CHAPTER 9 IN VITRO
STUDIES (Per E. Schwarze and Gerrit M. Alink). CHAPTER 10 EXPERIMENTAL
STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L.
Costa). CHAPTER 11 HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W.
Frampton, and Anders Blomberg). CHAPTER 12 PANEL STUDIES (Joel Schwartz).
PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. A.
ATHEROGENESIS. CHAPTER 13 PARTICULATES AND OXIDATIVE STRESS (Steffen Loft,
Roel P.F. Schins, and Peter Møller). CHAPTER 14 ROLE OF INFLAMMATION IN THE
ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David
Newby). CHAPTER 15 INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR
POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS
(Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler). CHAPTER
16 INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara
Hoffmann and Nino Künzli). CHAPTER 17 EFFECTS OF NANOPARTICLES ON THE
PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl,
and Dennis W. Wilson). CHAPTER 18 PARTICULATE MATTER, HYPERTENSION, AND THE
METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan). CHAPTER 19
PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R.
Miller). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. B.
VASCULAR DYSFUNCTION. PART IV. PARTICLES AND CARDIOVASCULAR DISEASE:
MECHANISMS. C. THROMBOSIS. CHAPTER 20 PARTICLES, COAGULATION, AND
THROMBOSIS (Evren Kilinç, Goran Rude~, Henri M.H. Spronk, Abderrahim
Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts). CHAPTER
21 PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and
Xiaohua Xu). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. D.
ARRHYTHMIA. CHAPTER 22 PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna
Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz). CHAPTER 23 AIR
POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend). PART
V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY. CHAPTER 24 RISK ASSESSMENT
(Robert L. Maynard and Jon G. Ayres). CHAPTER 25 ENVIRONMENTAL REGULATION
OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and
Sophie Punte). CHAPTER 26 FROM AMBIENT ULTRAFINE PARTICLES TO
NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).
INDEX.
CHAPTER 1 OVERVIEW (Flemming R. Cassee and Morton Lippmann). CHAPTER 2
ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION
(Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth). CHAPTER 3 CHRONIC
EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan,
Joel Kaufman, and Gerard Hoek). PART II. EXPOSURE. CHAPTER 4 PARTICLE
CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach). CHAPTER 5
EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef
Cyrys, H.-Erich Wichmann, and Jeroen de Hartog). CHAPTER 6 FROM EXPOSURE TO
DOSE (Werner Hofmann and Bahman Asgharian). CHAPTER 7 TRANSLOCATION OF
INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid,
Manuela Semmler-Behnke, and Günter Oberdörster). CHAPTER 8 ROLE OF CHEMICAL
COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew
J. Ghio and Yuh-Chin T. Huang). PART III. METHODOLOGY. CHAPTER 9 IN VITRO
STUDIES (Per E. Schwarze and Gerrit M. Alink). CHAPTER 10 EXPERIMENTAL
STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L.
Costa). CHAPTER 11 HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W.
Frampton, and Anders Blomberg). CHAPTER 12 PANEL STUDIES (Joel Schwartz).
PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. A.
ATHEROGENESIS. CHAPTER 13 PARTICULATES AND OXIDATIVE STRESS (Steffen Loft,
Roel P.F. Schins, and Peter Møller). CHAPTER 14 ROLE OF INFLAMMATION IN THE
ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David
Newby). CHAPTER 15 INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR
POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS
(Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler). CHAPTER
16 INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara
Hoffmann and Nino Künzli). CHAPTER 17 EFFECTS OF NANOPARTICLES ON THE
PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl,
and Dennis W. Wilson). CHAPTER 18 PARTICULATE MATTER, HYPERTENSION, AND THE
METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan). CHAPTER 19
PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R.
Miller). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. B.
VASCULAR DYSFUNCTION. PART IV. PARTICLES AND CARDIOVASCULAR DISEASE:
MECHANISMS. C. THROMBOSIS. CHAPTER 20 PARTICLES, COAGULATION, AND
THROMBOSIS (Evren Kilinç, Goran Rude~, Henri M.H. Spronk, Abderrahim
Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts). CHAPTER
21 PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and
Xiaohua Xu). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. D.
ARRHYTHMIA. CHAPTER 22 PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna
Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz). CHAPTER 23 AIR
POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend). PART
V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY. CHAPTER 24 RISK ASSESSMENT
(Robert L. Maynard and Jon G. Ayres). CHAPTER 25 ENVIRONMENTAL REGULATION
OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and
Sophie Punte). CHAPTER 26 FROM AMBIENT ULTRAFINE PARTICLES TO
NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).
INDEX.